263 related articles for article (PubMed ID: 30229844)
1. Fasudil alleviates hepatic fibrosis in type 1 diabetic rats: involvement of the inflammation and RhoA/ROCK pathway.
Xie Y; Song T; Huo M; Zhang Y; Zhang YY; Ma ZH; Wang N; Zhang JP; Chu L
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5665-5677. PubMed ID: 30229844
[TBL] [Abstract][Full Text] [Related]
2. Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, ameliorates hepatic fibrosis in rats with type 2 diabetes.
Zhou H; Fang C; Zhang L; Deng Y; Wang M; Meng F
Chin Med J (Engl); 2014; 127(2):225-31. PubMed ID: 24438608
[TBL] [Abstract][Full Text] [Related]
3. Fasudil ameliorates endothelial dysfunction in streptozotocin-induced diabetic rats: a possible role of Rho kinase.
Hofni A; Shehata Messiha BA; Mangoura SA
Naunyn Schmiedebergs Arch Pharmacol; 2017 Aug; 390(8):801-811. PubMed ID: 28493050
[TBL] [Abstract][Full Text] [Related]
4. The Rho kinase inhibitor, fasudil, ameliorates diabetes-induced cardiac dysfunction by improving calcium clearance and actin remodeling.
Lai D; Gao J; Bi X; He H; Shi X; Weng S; Chen Y; Yang Y; Ye Y; Fu G
J Mol Med (Berl); 2017 Feb; 95(2):155-165. PubMed ID: 27576917
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Rho kinase protects from ischaemia-reperfusion injury via regulation of arginase activity and nitric oxide synthase in type 1 diabetes.
Tratsiakovich Y; Kiss A; Gonon AT; Yang J; Sjöquist PO; Pernow J
Diab Vasc Dis Res; 2017 May; 14(3):236-245. PubMed ID: 28183205
[TBL] [Abstract][Full Text] [Related]
6. Chronic Rho-kinase inhibition improves left ventricular contractile dysfunction in early type-1 diabetes by increasing myosin cross-bridge extension.
Waddingham MT; Edgley AJ; Astolfo A; Inagaki T; Fujii Y; Du CK; Zhan DY; Tsuchimochi H; Yagi N; Kelly DJ; Shirai M; Pearson JT
Cardiovasc Diabetol; 2015 Jul; 14():92. PubMed ID: 26194354
[TBL] [Abstract][Full Text] [Related]
7. Rho kinase inhibition by fasudil ameliorates diabetes-induced microvascular damage.
Arita R; Hata Y; Nakao S; Kita T; Miura M; Kawahara S; Zandi S; Almulki L; Tayyari F; Shimokawa H; Hafezi-Moghadam A; Ishibashi T
Diabetes; 2009 Jan; 58(1):215-26. PubMed ID: 18840783
[TBL] [Abstract][Full Text] [Related]
8. Hydroxyl fasudil, an inhibitor of Rho signaling, improves erectile function in diabetic rats: a role for neuronal ROCK.
Sezen SF; Lagoda G; Musicki B; Burnett AL
J Sex Med; 2014 Sep; 11(9):2164-71. PubMed ID: 24919622
[TBL] [Abstract][Full Text] [Related]
9. Fasudil, an inhibitor of Rho-associated coiled-coil kinase, attenuates hyperoxia-induced pulmonary fibrosis in neonatal rats.
Qi XJ; Ning W; Xu F; Dang HX; Fang F; Li J
Int J Clin Exp Pathol; 2015; 8(10):12140-50. PubMed ID: 26722398
[TBL] [Abstract][Full Text] [Related]
10. Rho-Associated Protein Kinase-1 Mediates the Regulation of Inflammatory Markers in Diabetic Retina and in Retinal Müller Cells.
Mohammad G; AlSharif HM; Siddiquei MM; Ahmad A; Alam K; Abu El-Asrar AM
Ann Clin Lab Sci; 2018 Mar; 48(2):137-145. PubMed ID: 29678838
[TBL] [Abstract][Full Text] [Related]
11. Chronic treatment with an oral rho-kinase inhibitor restores erectile function by suppressing corporal apoptosis in diabetic rats.
Li WJ; Park K; Paick JS; Kim SW
J Sex Med; 2011 Feb; 8(2):400-10. PubMed ID: 20233282
[TBL] [Abstract][Full Text] [Related]
12. Acute Rho-kinase inhibition improves coronary dysfunction in vivo, in the early diabetic microcirculation.
Pearson JT; Jenkins MJ; Edgley AJ; Sonobe T; Joshi M; Waddingham MT; Fujii Y; Schwenke DO; Tsuchimochi H; Yoshimoto M; Umetani K; Kelly DJ; Shirai M
Cardiovasc Diabetol; 2013 Aug; 12():111. PubMed ID: 24059472
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Rho-kinase ameliorates myocardial remodeling and fibrosis in pressure overload and myocardial infarction: role of TGF-β1-TAK1.
Li Q; Xu Y; Li X; Guo Y; Liu G
Toxicol Lett; 2012 Jun; 211(2):91-7. PubMed ID: 22465603
[TBL] [Abstract][Full Text] [Related]
14. Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, suppresses isoproterenol-induced heart failure in rats via JNK and ERK1/2 pathways.
Wang N; Guan P; Zhang JP; Li YQ; Chang YZ; Shi ZH; Wang FY; Chu L
J Cell Biochem; 2011 Jul; 112(7):1920-9. PubMed ID: 21433064
[TBL] [Abstract][Full Text] [Related]
15. Long-term administration of fasudil improves cardiomyopathy in streptozotocin-induced diabetic rats.
Guan SJ; Ma ZH; Wu YL; Zhang JP; Liang F; Weiss JW; Guo QY; Wang JY; Ji ES; Chu L
Food Chem Toxicol; 2012 Jun; 50(6):1874-82. PubMed ID: 22429817
[TBL] [Abstract][Full Text] [Related]
16. Fasudil, a Rho-Associated Coiled Coil-Forming Protein Kinase Inhibitor, Recovers Methylmercury-Induced Axonal Degeneration by Changing Microglial Phenotype in Rats.
Fujimura M; Usuki F; Nakamura A
Toxicol Sci; 2019 Mar; 168(1):126-136. PubMed ID: 30462329
[TBL] [Abstract][Full Text] [Related]
17. Rho/Rho kinase is a key enzyme system involved in the angiotensin II signaling pathway of liver fibrosis and steatosis.
Kitamura K; Tada S; Nakamoto N; Toda K; Horikawa H; Kurita S; Tsunematsu S; Kumagai N; Ishii H; Saito H; Hibi T
J Gastroenterol Hepatol; 2007 Nov; 22(11):2022-33. PubMed ID: 17914985
[TBL] [Abstract][Full Text] [Related]
18. The Rho-kinase inhibitor, fasudil, attenuates diabetic nephropathy in streptozotocin-induced diabetic rats.
Gojo A; Utsunomiya K; Taniguchi K; Yokota T; Ishizawa S; Kanazawa Y; Kurata H; Tajima N
Eur J Pharmacol; 2007 Jul; 568(1-3):242-7. PubMed ID: 17511984
[TBL] [Abstract][Full Text] [Related]
19. Rho kinase inhibition by fasudil has anti-inflammatory effects in hypercholesterolemic rats.
Ma Z; Zhang J; Du R; Ji E; Chu L
Biol Pharm Bull; 2011; 34(11):1684-9. PubMed ID: 22040880
[TBL] [Abstract][Full Text] [Related]
20. Role of linagliptin in preventing the pathological progression of hepatic fibrosis in high fat diet and streptozotocin-induced diabetic obese rats.
Aboulmagd YM; El-Bahy AAZ; Menze ET; Azab SS; El-Demerdash E
Eur J Pharmacol; 2020 Aug; 881():173224. PubMed ID: 32454118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
